| scholarly article | Q13442814 |
| P50 | author | Takafumi Tsuboi | Q63860522 |
| Jetsumon Sattabongkot | Q60048856 | ||
| P2093 | author name string | Motomi Torii | |
| Takeshi Miyata | |||
| Kozue Sakao | |||
| Takeshi Arakawa | |||
| P2860 | cites work | Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay | Q70074596 |
| Proton nuclear magnetic resonance sequential assignments and secondary structure of an immunoglobulin light chain-binding domain of protein L | Q70631304 | ||
| B cells as antigen-presenting cells: the requirement for B cell activation | Q72701602 | ||
| A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G | Q27651724 | ||
| High-resolution solution NMR structure of the Z domain of staphylococcal protein A | Q27745628 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Coiled coils: new structures and new functions | Q29555849 | ||
| The neglected burden of Plasmodium vivax malaria | Q29618450 | ||
| Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. | Q33350210 | ||
| Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes | Q34005142 | ||
| Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum | Q34111897 | ||
| Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization | Q34119427 | ||
| Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle | Q34341570 | ||
| The structure of alpha-helical coiled coils | Q34412200 | ||
| Transmission-blocking vaccine of vivax malaria | Q35051320 | ||
| Molecular Mechanisms of B Cell Antigen Receptor Trafficking | Q35119884 | ||
| Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development | Q35272875 | ||
| B-cell antigen-receptor signalling in lymphocyte development | Q35591032 | ||
| Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates | Q35925379 | ||
| Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial | Q35925829 | ||
| A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity | Q36221727 | ||
| Immunogenicity of Plasmodium falciparum sexual stage antigens: Implications for the design of a transmission blocking vaccine | Q36624433 | ||
| The molecular assembly and organization of signaling active B-cell receptor oligomers. | Q37631686 | ||
| Boosting antibody responses by targeting antigens to dendritic cells | Q37966312 | ||
| Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine | Q39255944 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Structures of bacterial immunoglobulin-binding domains and their complexes with immunoglobulins | Q40927379 | ||
| A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains | Q43525538 | ||
| Public health challenges and prospects for malaria control and elimination | Q43881419 | ||
| Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes | Q44068863 | ||
| Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria | Q44164504 | ||
| Dendritic cell-independent B cell activation during acute virus infection: a role for early CCR7-driven B-T helper cell collaboration | Q45408169 | ||
| Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. | Q46017170 | ||
| Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future. | Q51772228 | ||
| P433 | issue | 4 | |
| P921 | main subject | malaria transmission | Q56928847 |
| P304 | page(s) | 561-569 | |
| P577 | publication date | 2014-02-12 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Tricomponent complex loaded with a mosquito-stage antigen of the malaria parasite induces potent transmission-blocking immunity | |
| P478 | volume | 21 |
| Q27974539 | Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine |
| Q92001627 | Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites |
| Q110697582 | Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation |
Search more.